Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Period	Milestone	Group	Participants
Overall Study	STARTED	Selonsertib	39
Overall Study	STARTED	Firsocostat	40
Overall Study	STARTED	Cilofexor	41
Overall Study	STARTED	SEL + FIR	80
Overall Study	STARTED	SEL + CILO	78
Overall Study	STARTED	FIR + CILO	78
Overall Study	STARTED	Placebo	39
Overall Study	COMPLETED	Selonsertib	3
Overall Study	COMPLETED	Firsocostat	33
Overall Study	COMPLETED	Cilofexor	34
Overall Study	COMPLETED	SEL + FIR	71
Overall Study	COMPLETED	SEL + CILO	66
Overall Study	COMPLETED	FIR + CILO	69
Overall Study	COMPLETED	Placebo	38
Overall Study	NOT COMPLETED	Selonsertib	36
Overall Study	NOT COMPLETED	Firsocostat	7
Overall Study	NOT COMPLETED	Cilofexor	7
Overall Study	NOT COMPLETED	SEL + FIR	9
Overall Study	NOT COMPLETED	SEL + CILO	12
Overall Study	NOT COMPLETED	FIR + CILO	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03449446/flow